Clinical trial
Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant…
NCT00335985 · Japan Blood Products Organization, Industry · Completed
Key facts
| NCT number | NCT00335985 |
|---|---|
| Title | Efficacy and Safety Study of GB-0998 for Treatment of Steroid-resistant Polymyositis and Dermatomyositis (PM/DM) |
| Official title | A Randomized, Double-blind, Controlled Clinical Study of GB-0998 for the Steroid-resistant Polymyositis and Dermatomyositis |
| Lead sponsor | Japan Blood Products Organization, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Polymyositis, Dermatomyositis |
| Intervention type | Drug |
| Interventions | GB-0998, Placebo of GB-0998 |
| Enrollment | 26 |
| Start date | Jun 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Jun 12, 2006 |
| Last update posted | Nov 5, 2014 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: